EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial

Viktoriya L Nikolova, Anthony J Cleare, Allan H Young, James M Stone

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2025.01.153 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Viktoriya L Nikolova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Affective Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, SE5 8AF London, UK; ADM Health & Wellness,…. Hauptthemen laut MEDLINE: Probiotics, Major Depressive Disorder, Gastrointestinal Microbiome, Antidepressive Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council, King's College London, South London and Maudsley NHS Foundation Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We previously reported greater reductions in depression and anxiety following probiotic supplementation in people with major depressive disorder (MDD) in a randomised double-blind placebo-controlled pilot trial (Nikolova et al., 2023). Here, we investigate the mechanisms underlying these effects. METHODS: 49 people with MDD received a multi-strain probiotic (n = 24) or placebo (n = 25) for 8 weeks in addition to their antidepressant. Stool and blood samples were collected to analyse gut microbiota composition and inflammatory cytokines. Stool samples from 25 matched healthy volunteers (HVs) were also obtained. RESULTS: Within the probiotic group, there was a significant increase in richness according to Chao1(bias-corrected) (w4 p = 0.04) and a trend for increased Total count (w4 p = 0.06, w8 p = 0.09) compared to baseline, but not to placebo. When compared to HVs post-treatment, only the placebo group had a significant decrease in Shannon' entropy (p = 0.03) and a trend for decreased Total count (p = 0.08) and Simpson's index (p = 0.09). Between-group differences in beta diversity were observed at week 4 (p = 0.04), but not week 8. Consistent between-group differences were seen in family Bacilleceae post-treatment (FDR p < 0.05), which correlated with decreases in anxiety (FDR p < 0.05). There were no differences in inflammatory markers. LIMITATIONS: This study was limited by data loss during the COVID-19 Pandemic. CONCLUSION: Probiotics may positively impact the microbiota by normalising diversity and increasing levels of health-related taxa, which may partially account for their benefits in MDD. Understanding how these changes relate to symptom improvement can inform their targeted use in clinical practice. Larger trials incorporating functional multi-omics are needed. TRIAL REGISTRATION: NCT03893162.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsMajor Depressive DisorderGastrointestinal MicrobiomeAntidepressive AgentsHumansMalePilot ProjectsFemaleAdultMiddle AgedDouble-Blind MethodFecesCytokines

Stichwörter der Autor:innen

Clinical trialDepressionGut microbiotaProbiotics

Substanzen

CytokinesAntidepressive Agents

Autor:innen und Institutionen

  • Centre for Affective Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, SE5 8AF London, UK; ADM Health & Wellness, ADM Protexin Ltd., Somerset, UK. Electronic address: viktoriya.nikolo…
  • Centre for Affective Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, SE5 8AF London, UK; National Institute for Health Research Biomedical Research Centre at South London and Maudsl…
  • Centre for Affective Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, SE5 8AF London, UK; Brighton and Sussex Medical School, Brighton BN1 9PX, UK. Electronic address: j.stone@bsms.a…

Förderung

  • UK Research and Innovation Medical Research Council
  • King's College London
  • South London and Maudsley NHS Foundation Trust
  • National Institute for Health and Care Research

Zitieren

APA

Nikolova, V. L., Cleare, A. J., Young, A. H., & Stone, J. M. (2025). Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.01.153

Vancouver

Nikolova VL, Cleare AJ, Young AH, Stone JM. Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.01.153

BibTeX
@article{Nikolova2025,
  author = {Nikolova, Viktoriya L and Cleare, Anthony J and Young, Allan H and Stone, James M},
  title = {Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2025.01.153}
}
Kostenlos starten →